KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 136 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 0.74 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $42,000 | -81.2% | 10,300 | -78.4% | 0.00% | -85.7% |
| Q1 2016 | $223,000 | -36.3% | 47,664 | -31.3% | 0.01% | -17.6% |
| Q4 2015 | $350,000 | +297.7% | 69,376 | +176.0% | 0.02% | +325.0% |
| Q3 2015 | $88,000 | -22.1% | 25,140 | +122.5% | 0.00% | 0.0% |
| Q2 2015 | $113,000 | -86.1% | 11,300 | -82.3% | 0.00% | -87.5% |
| Q1 2015 | $814,000 | +150.5% | 63,937 | +235.4% | 0.03% | +39.1% |
| Q1 2014 | $325,000 | -26.8% | 19,062 | -56.6% | 0.02% | -34.3% |
| Q3 2013 | $444,000 | – | 43,916 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management I, LLC | 1,312,006 | $22,357,000 | 15.70% |
| VHCP Management, LLC | 1,000,273 | $17,045,000 | 8.86% |
| HARVEY CAPITAL MANAGEMENT INC | 915,800 | $15,605,000 | 6.22% |
| Baupost Group | 6,310,850 | $107,537,000 | 2.60% |
| SECTORAL ASSET MANAGEMENT INC | 3,537,590 | $60,281,000 | 2.48% |
| INSIGHT CAPITAL RESEARCH & MANAGEMENT INC | 587,504 | $10,011,000 | 2.31% |
| Knoll Capital Management, LLC | 200,000 | $3,408,000 | 1.76% |
| Camber Capital Management LP | 1,250,000 | $21,300,000 | 1.67% |
| NORTHPOINTE CAPITAL LLC | 877,875 | $14,958,000 | 1.52% |
| DAFNA Capital Management LLC | 100,000 | $1,704,000 | 1.46% |